Question 1

What specific urine tests will be done to check for kidney injury?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) clinical trial (NCT04393428). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results of these tests affect my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) clinical trial (NCT04393428). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with these urine tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) clinical trial (NCT04393428). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this study help improve care for COVID-19 patients in the future?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) clinical trial (NCT04393428). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if the tests show that I am at risk for kidney injury?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) clinical trial (NCT04393428). Contact the study team or your healthcare provider for specific answers.

What this study is about